LENZ · NASDAQ · Biotechnology

LENZ (LENZ)

Commercializes VIZZ, an FDA-approved aceclidine eye drop for adult presbyopia.

$4.18
After hours+0.05 (+1.26%)
At close$4.13(+1.10%)